Wave Life Sciences

Every day, we are inspired by patients and families living with life-altering diseases. Their stories drive us to deliver transformational RNA medicines with urgency. After a ten-year misdiagnosis, Caffrey and his family have been navigating their #Duchenne journey for the past four years. We are grateful to have spent time with them to learn how they found their new normal and what gives them hope for the future. #ReimaginePossible #InspirationToImpact

Aligned with one of our values of inclusion, our Women+ of Wave Employee Resource Group recently hosted a panel discussion moderated by Wave's Chelley Casey. Senior leaders Clara Gil, Daryn Lewis, Suki Malhi and Ginnie (HsiuChiung) Yang discussed their personal and professional journeys while sharing advice for success. Key takeaways included: stay authentic, ask for help, and always support other women's wins.

Congratulations to our President and CEO Paul Bolno for being included as a contender for STAT’s “Best Biopharma CEO”. This is a wonderful way to cap off a year of scientific achievements at Wave. Thank you, Paul, for your leadership and for your unrelenting belief in our opportunity to unlock the broad potential of RNA medicines.

As part of our annual holiday giving activities, Wave employees recently visited residents of our local CareOne nursing and assisted living facility for a festive performance! Thank you to CareOne for letting us be part of your holiday season and to our employees who showcased their talents and holiday spirit. #InspirationIntoImpact #WeAreWave

Meet Wei, who is part of our Translational Medicine team. From helping to establish one of our leading RNA-targeting modalities, to supporting the progression of our WVE-007 program targeting INHBE for obesity, Wei is a key contributor at Wave. Learn more about his journey in his #EmployeeSpotlight. #WeAreWave #ReimaginePossible

Happy #Thanksgiving from everyone at Wave! We are grateful for our colleagues and partners from the patient, research, and medical communities. Your dedication and hard work inspire us every day. As we gather to celebrate this holiday, we wish you all a joyous and healthy time with your loved ones. Thank you for being an integral part of our journey.

In support of #Alpha1Awareness month, the Wave team laced up their sneakers for a virtual walk. Together, we took steps to raise awareness and support those affected by Alpha-1 Antitrypsin Deficiency. Every stride counts in spreading knowledge and hope. Let's continue to raise our voices and make a difference for the Alpha-1 community! #Alpha1 #AATD

Join our Chief Development Officer, Anne-Marie Li-Kwai-Cheung, for a Jett Foundation discussion on FORWARD-53, our WVE-N531 clinical trial in boys with #Duchenne muscular dystrophy amenable to exon 53 skipping.

This week in observance of #Alpha1Awareness month, Dan, living with #Alpha1, joined us on campus. After his diagnosis at 61 years old, Dan stepped into the role of being his own advocate while also providing a source for comfort and support of others in their Alpha-1 journey. Thank you, Dan, for all you do for the Alpha-1 Foundation and for inspiring all of us at Wave.

Today we announced our 3Q 2024 results and provided updates across our diverse portfolio of innovative #RNA medicines, including our lead programs in #HuntingtonsDisease, #AATD, #Duchenne & #obesity, as well as our emerging #RNAediting programs in cardiometabolic diseases. Read more and watch the webcast: https://lnkd.in/en4-55uE